pharmabiz.com

GENERAL
META
HTML
LINK ANALYSIS
SERVER
IP

Pharmabiz.com recives any estimated n/a unique visitors and n/a unique page views per day. Revenue gained from these much visits may be n/a per day from various advertising sources. The estimated worth of site is n/a.

Website Age n/a
Alexa Rank no-data
Country India
IP Address 203.115.122.29

META INFORMATION

Title

India's most comprehensive portal on pharmaceutical News, Tenders, Patents, Notifications, Projects, Stocks, Drugs & Medicines

Description

Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, pharma projects, pharma export & import, pharma laws & doc***ents, pharma policies, pharma events, pharma company profiles, pharma studies, pharma marketing

Keywords

Indian Pharma, Pharmabiz, Pharma Labs, Pharma Patents, Pharma Events, US FDA, Pharma Drugs, Clinical Trials, Clinical Research & Services, Pharma Marketing, Indian Pharmacy, Pharma Laws & Doc***ents, Chronicle Pharmabiz, Biotechnology, Pharma Product Launch, Pharma Corporate, Formulation Development

Content Type

KEYWORDS AND KEYWORD DENSITY

No	Keyword	Website Count
1	Clinical trials	8
2	Biotechnology	12

google ads

GENERAL HTML INFORMATION

Type	Status
HTML 5
Responsive Website

HTML SIZE INFORMATION

Text / Code Ratio 7.93 %

pharmabiz.com has a website text/code ratio of 7.93 %. Search engine crawlers tend to not pick up pages with inadequate content.

IMPORTANT HTML TAGS AND COUNTS

Titles

Text Styling

STRONG23
B9
EM0
I0
U0
CITE0

STRONG

No	Text
1	Join Pharma
2	\|
3	Login
4	Editorial
5	TODAY'S NEWS
6	more news >> (3)
7	TOP NEWS
8	YESTERDAY'S NEWS
9	INTERVIEW
10	What's New?
11	Opinion Poll
12	Corporate
13	Special Features
14	Chronicle Pharmabiz Specials
15	Forthcoming Events
16	TENDERS & PROJECTS
17	CORPORATE
18	US FDA UPDATE
19	EXPORT & IMPORT
20	PHARMA LAWS & DOc***ENTS
21	LIST OF LABS & GOVT. BODIES

No	Text
1	Home
2	Editorial
3	Services
4	Interview
5	Q&A
6	Chronicle Specials
7	Pharma Mart
8	ePharmail
9	Archives

LINK ANALYSIS

Total Link Count: 137

Internal Link Count : 128

No	Text	Type
1	Home	text
2	Editorial	text
3	Services	text
4	Interview	text
5	Q&A	text
6	Chronicle Specials	text
7	Pharma Mart	text
8	ePharmail	text
9	Archives	text
10	Tenders & Project	text
11	Tenders & Enquiries	text
12	Pharma Projects	text
13	Corporate	text
14	Company Profiles	text
15	Corporate Results	text
16	Corporate X-ray	text
17	Pharmabiz Studies of Top Companies	text
18	US FDA UPDATE	text
19	US FDA: ANDA	text
20	US FDA: Warnings	text
21	US FDA: Approved NMEs	text
22	US FDA: New Approvals	text
23	US FDA: REFUSAL	text
24	EXPORT & IMPORT	text
25	Drug Export Procedures	text
26	Drug Units With WHO GMP Certification	text
27	Pharma Export Data	text
28	Import Reg. Update	text
29	PHARMA LAWS & DOc***ENTS	text
30	Notifications	text
31	Pharma Regulations	text
32	Patent Laws and Amendments	text
33	Patent Scan	text
34	Doc***ents	text
35	New Drug Approvals	text
36	Notified Prices	text
37	LIST OF LABS & GOVT. BODIES	text
38	Govt Recognised In-House R&D Units	text
39	AICTE Boards & Committees	text
40	List of Indian CROs	text
41	List of CROs (International)	text
42	Govt & approved labs of India	text
43	List of State Drugs Controllers	text
44	Onconova Therapeutics initiates phase 1/2a study of rigosertib plus nivolumab to treat KRAS+ lung adenocarcinoma	text
45	IMPORTANT NOTICE ON CHRONICLE PHARMABIZ - Click Here	text
46	Join Pharma	text
47	Login	text
48	GUIDELINES ON TELEMEDICINE	text
49	Past Editorial...	text
50	Onconova Therapeutics initiates phase 1/2a study of rigosertib plus nivolumab to treat KRAS+ lung adenocarcinoma	text